Kambara, Takahiro
Shibata, Rei
Sakamoto, Yuusuke
Sakaguchi, Teruhiro
Osanai, Hiroyuki
Nakashima, Yoshihito
Asano, Hiroshi
Murohara, Toyoaki
Ajioka, Masayoshi
Article History
Received: 31 July 2023
Accepted: 21 February 2024
First Online: 1 March 2024
Declarations
:
: The requirement of informed consent was waived based on the Japanese Ministry of Health, Labour and Welfare guidelines (Ethical Guidelines for Medical and Biological Research Involving Human Subjects: Section 8). In regard to the use of their data, patients could opt out of the study via the hospital website. The study was approved by the Ethics Committee of Tosei General Hospital (No.1002, Aichi, Japan). All study procedures complied with the Declaration of Helsinki.
: The authors affirm that participants provided written informed consent for the study’s publication.
: R.S. has received lecture fees from Boehringer Ingelheim, Eli Lilly, Mitsubishi Tanabe Pharma, Novartis and Astrazeneca. R.S. is also affiliated with a department endowed by Medtronic. Other authors do not have any competing interest.